Fox Chase Cancer Center: Model Estimated Increased Cure Rate Associated With Adjuvant Nivolumab for Muscle-Invasive Urothelial Carcinoma

Press/Media

PeriodJan 26 2024

Media coverage

1

Media coverage

  • TitleFox Chase Cancer Center: Model Estimated Increased Cure Rate Associated With Adjuvant Nivolumab for Muscle-Invasive Urothelial Carcinoma
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date01/26/24
    PersonsDaniel Geynisman